Clinical Trial Update: Glucocorticoid Therapy for Acute Respiratory Distress Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial of glucocorticoid therapy for Acute Respiratory Distress Syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Glucocorticoid therapy (glucocorticoids)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Acute Respiratory Distress Syndrome | Phase 2 | Status: WITHDRAWN